» Articles » PMID: 35414002

Diagnostic Utility of Antigen Detection Rapid Diagnostic Tests for Covid-19: a Systematic Review and Meta-analysis

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2022 Apr 13
PMID 35414002
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The early detection of coronavirus disease (COVID-19) infection to improve disease management becomes the greatest challenge. Despite the high sensitivity of RT-PCR, not only it was reported that 20-67% of infected patients had false-negative results. Rapid diagnostic tests (RDTs) are widely used as a point-of-care test for SARS-CoV-2 detection in pharyngeal and blood specimens. It's more appealing since it's less time-consuming, doesn't seem to be as expensive, and doesn't need any specific training, but the poor sensitivity is the major limitation. Several reports indicated the rapid test of blood and pharyngeal samples has the same sensitivity as the RT-PCR, but some reports have lower sensitivity, especially in asymptomatic patients.

Methods: In the present survey, we investigate the eligible studies for the sensitivity and specificity of rapid tests and explore the factors that influence the result to help better diagnose COVID-19 infection. 20 studies met the inclusion criteria which imposed 33 different tests.

Results: Our findings showed the type of sample, the type of assay, the time of sampling, and the load of virus influence on the sensitivity of RDTs.

Conclusion: This research extends our knowledge of how to improve the sensitivity of RDTs to better diagnose the infected patients to address the controlling COVID-19 pandemic.

Citing Articles

Feasibility of snapshot testing using wearable sensors to detect cardiorespiratory illness (COVID infection in India).

Botonis O, Mendley J, Aalla S, Veit N, Fanton M, Lee J NPJ Digit Med. 2024; 7(1):289.

PMID: 39427067 PMC: 11490565. DOI: 10.1038/s41746-024-01287-2.


Performance of Blood-Based Nucleocapsid Antigen Tests for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Infectious Viral Shedding: A Systematic Review.

Mathur S, So M, Tahir P, Peluso M, Martin J, Kelly J Open Forum Infect Dis. 2023; 10(8):ofad346.

PMID: 37547852 PMC: 10400123. DOI: 10.1093/ofid/ofad346.


Evaluation of the diagnostic accuracy of two point-of-care tests for COVID-19 when used in symptomatic patients in community settings in the UK primary care COVID diagnostic accuracy platform trial (RAPTOR-C19).

Nicholson B, Turner P, Fanshawe T, Williams A, Amirthalingam G, Tonner S PLoS One. 2023; 18(7):e0288612.

PMID: 37478103 PMC: 10361479. DOI: 10.1371/journal.pone.0288612.


Diagnostic performance of standardized typical CT findings for COVID-19: a systematic review and meta-analysis.

Nam B, Hong H, Yoon S Insights Imaging. 2023; 14(1):96.

PMID: 37222857 PMC: 10206568. DOI: 10.1186/s13244-023-01429-2.


The First Identification in Italy of SARS-CoV-2 Omicron BA.4 Harboring KSF141_del: A Genomic Comparison with Omicron Sub-Variants.

Peronace C, Tallerico R, Colosimo M, Fazio M, Pasceri F, Talotta I Biomedicines. 2022; 10(8).

PMID: 36009386 PMC: 9405011. DOI: 10.3390/biomedicines10081839.


References
1.
Wiersinga W, Rhodes A, Cheng A, Peacock S, Prescott H . Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020; 324(8):782-793. DOI: 10.1001/jama.2020.12839. View

2.
Courtellemont L, Guinard J, Guillaume C, Giache S, Rzepecki V, Seve A . High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection. J Med Virol. 2021; 93(5):3152-3157. PMC: 8014580. DOI: 10.1002/jmv.26896. View

3.
Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S . The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro. J Clin Med. 2021; 10(2). PMC: 7830733. DOI: 10.3390/jcm10020328. View

4.
Birks J . Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006; (1):CD005593. PMC: 9006343. DOI: 10.1002/14651858.CD005593. View

5.
Linares M, Perez-Tanoira R, Carrero A, Romanyk J, Perez-Garcia F, Gomez-Herruz P . Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms. J Clin Virol. 2020; 133:104659. PMC: 7561603. DOI: 10.1016/j.jcv.2020.104659. View